Skip to main content
PharmAbcine Inc. logo

PharmAbcine Inc. — Investor Relations & Filings

Ticker · 208340 ISIN · KR7208340000 KO Manufacturing
Open in API
Filings indexed 461 across all filing types
Latest filing 2020-06-15 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 208340

About PharmAbcine Inc.

http://pharmabcine.com/

PharmAbcine Inc. is a clinical-stage biotechnology company specializing in the development of fully human therapeutic monoclonal antibodies (mAbs). The company focuses on creating innovative treatments for diseases with high unmet medical needs, primarily in oncology, neovascular eye diseases, and other inflammatory and vascular disorders. Utilizing its proprietary human antibody library and discovery technologies, PharmAbcine advances a pipeline of next-generation IgG-based therapeutics. The company's mission is to contribute to human health by providing novel antibody-based drugs to patients.

Recent filings

Filing Released Lang Actions
주주명부폐쇄기간또는기준일설정
Share Issue/Capital Change Classification · 100% confidence The document is a short regulatory announcement regarding the suspension of share registration (shareholder register closure) for the purpose of allocating new shares due to a bonus issue (free capital increase). It does not contain full financial statements or detailed reports, but rather serves as a specific corporate action notice. Given the nature of the announcement regarding capital changes and shareholder records, it fits best under the general regulatory filing category as it is a standard KRX disclosure.
2020-06-15 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). It details the share transactions (disposal of 30,000 shares) by an executive (Lee Won-sup) of PharmAbcine. This is a standard regulatory filing for insider trading/director dealings in the Korean market, which corresponds to the 'Director's Dealing' category.
2020-06-08 Korean
분기보고서 (2020.03)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for the company 'PharmAbcine' (주)파멥신 for the first quarter of 2020 (2020년 01월 01일 ~ 2020년 03월 31일). It contains detailed company information, financial data, business operations, and management discussions, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2020
2020-05-15 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. This type of filing is specifically used to report changes in share ownership by company insiders (directors/executives). According to the provided definitions, this falls under 'Director's Dealing' (DIRS), which covers personal share transactions and changes in holdings by company directors and executives.
2020-04-02 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. This type of filing is a mandatory disclosure by company insiders (directors/executives) regarding their personal shareholdings and transactions. In the provided taxonomy, this corresponds to 'Director's Dealing' (DIRS), which covers personal share transactions by company directors and executives.
2020-04-02 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서) filed with the Financial Supervisory Service (FSS) in South Korea. It details changes in share ownership by a major shareholder (the CEO, Yoo Jin-san) and related parties, including changes in board members and stock option grants. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema, as it tracks significant ownership thresholds and changes in control.
2020-04-02 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.